Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aura Biosciences (AURA) Change in Cash (2020 - 2026)

Aura Biosciences filings provide 7 years of Change in Cash readings, the most recent being $25.3 million for Q1 2026.

  • Quarterly Change in Cash rose 286.1% to $25.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $46.8 million through Mar 2026, up 290.7% year-over-year, with the annual reading at $28.0 million for FY2025, 398.31% up from the prior year.
  • Change in Cash hit $25.3 million in Q1 2026 for Aura Biosciences, up from $12.1 million in the prior quarter.
  • Across five years, Change in Cash topped out at $69.1 million in Q2 2025 and bottomed at -$83.1 million in Q1 2023.
  • Average Change in Cash over 5 years is -$3.7 million, with a median of $6.3 million recorded in 2024.
  • Peak annual rise in Change in Cash hit 1721.18% in 2025, while the deepest fall reached 1181.06% in 2025.
  • Aura Biosciences' Change in Cash stood at $60.3 million in 2022, then plummeted by 124.08% to -$14.5 million in 2023, then skyrocketed by 143.29% to $6.3 million in 2024, then surged by 92.84% to $12.1 million in 2025, then soared by 108.75% to $25.3 million in 2026.
  • Per Business Quant, the three most recent readings for AURA's Change in Cash are $25.3 million (Q1 2026), $12.1 million (Q4 2025), and -$59.8 million (Q3 2025).